These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 379471)

  • 1. [Acute effects of bumetanide in healthy subjects. A comparative study with furosemide (author's transl)].
    Ortź González A; Méndez Martin A
    Med Clin (Barc); 1979 Mar; 72(6):259-64. PubMed ID: 379471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furosemide and bumetanide: a study of responses in normal English and German subjects.
    Branch RA; Read PR; Levine D; Elst EV; Shelton J; Rupp W; Ramsay LE
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):538-45. PubMed ID: 1277709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of the effects of furosemide, ethacrynic acid and bumetanide on the lithium clearance and diluting segment reabsorption in humans.
    Beutler JJ; Boer WH; Koomans HA; Dorhout Mees EJ
    J Pharmacol Exp Ther; 1992 Feb; 260(2):768-72. PubMed ID: 1738122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
    Cohen MR; Hinsch E; Vergona R; Ryan J; Kolis SJ; Schwartz MA
    J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diuretic activity of bumetanide in a controlled comparison with furosemide in patients with various degrees of impaired renal function (author's transl)].
    Kampf D; Baethke R
    Arzneimittelforschung; 1980; 30(6):1015-8. PubMed ID: 7191261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations of the early diuretic response after intravenous administration of bumetanide and furosemide in dogs.
    Olsen UB
    Acta Physiol Scand; 1975 Feb; 93(2):195-201. PubMed ID: 1146571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Result of the administration of high doses of bumetanide to patients with chronic renal failure who are on a program of hemodialysis (author's transl)].
    del Río Vázquez A; Carrera Carbó F; Arcocha Gilo V; Torrente Sierra J
    Med Clin (Barc); 1979 Jan; 72(2):71-3. PubMed ID: 431166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bumetanide, a new diuretic active during chronic renal failure (author's transl)].
    Fries D; Beroniade V; Coy JL; Delavelle F
    Pathol Biol (Paris); 1976 Jun; 24(6):435-9. PubMed ID: 785349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diuretic evaluation of bumetanide (author's transl)].
    Barrientos Guzmán A; Ortuño de Solo MT
    Med Clin (Barc); 1979 Nov; 73(8):338-41. PubMed ID: 522529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological properties of the novel highly potent diuretic 7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid potassium salt.
    Shinkawa T; Yamasaki F; Kikuchi A; Nakakuki M; Nishijima K; Uemura A; Mizota M; Orita Y
    Arzneimittelforschung; 1992 Dec; 42(12):1466-72. PubMed ID: 1337698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some aspects of the renal action and clinical pharmacology of oral bumetanide in man.
    Bourke E
    Postgrad Med J; 1975; 51 Suppl 6():23-26. PubMed ID: 1105529
    [No Abstract]   [Full Text] [Related]  

  • 12. Open comparison of diuretic effects of piretanide and bumetanide in patients with stable renal transplants.
    Bailey RR
    N Z Med J; 1982 Jan; 95(700):44-5. PubMed ID: 7038567
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic and natriuretic effects of bumetanide and furosemide in the cat.
    Friedman PA; Roch-Ramel F
    J Pharmacol Exp Ther; 1977 Oct; 203(1):82-91. PubMed ID: 909060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of bumetanide in nephrotic syndrome: a double-blind crossover study with furosemide.
    Lau K; DeFronzo R; Morrison G; Rascoff J; Goldberg M; Agus ZS
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):489-97. PubMed ID: 789411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bumetanide and frusemide: a comparison of dose-response curves in healthy men.
    Ramsay LE; McInnes GT; Hettiarachchi J; Shelton J; Scott P
    Br J Clin Pharmacol; 1978 Mar; 5(3):243-7. PubMed ID: 656269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men.
    Ohnishi A; Orita Y; Okahara R; Fujihara H; Inoue T; Yamamura Y; Yabuuchi Y; Tanaka T
    J Clin Invest; 1993 Dec; 92(6):2653-9. PubMed ID: 8254021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineral excretion following furosemide compared with bumetanide therapy in premature infants.
    Shankaran S; Liang KC; Ilagan N; Fleischmann L
    Pediatr Nephrol; 1995 Apr; 9(2):159-62. PubMed ID: 7794709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects.
    Roberts CJ; Homeida M; Roberts F; Bogie W
    Br J Clin Pharmacol; 1978 Aug; 6(2):129-33. PubMed ID: 678389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bumetanide stimulation of sodium permeability of the apical membrane of toad urinary bladder.
    Li JH; Kau ST
    J Pharmacol Exp Ther; 1988 Sep; 246(3):980-5. PubMed ID: 2843638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bumetanide, a new loop diuretic.
    Carrière S; Dandavino R
    Clin Pharmacol Ther; 1976 Oct; 20(4):424-38. PubMed ID: 788989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.